Dunkin' Donuts has so many coffee options, and some of them are bursting with caffeine. So what's the most caffeinated drink ...

President Donald Trump's new tariff orders against Canada, Mexico and China all contain clauses suspending a duty-free ...

Trump’s move to impose new tariffs has bewildered the United States’ closest allies and trading partners, who have vowed to ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...

Trump tariffs cannot deter Starmer from seeking closer EU ties - THE INDEPENDENT VIEW: Editorial: The threat of Trump tariffs ...

Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...

The agency warned that the products, made by Cal Yee Farm, could have potentially serious or even deadly consequences because ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.